Radioisotope manufacturer International Isotopes has posted increased revenue for its 2025 first quarter.
For the period (end-March 31), the company reported revenue of $3.2 million, up 12% from $2.9 million in the first quarter of 2024. It attributed the uptick to growth of sales of its nuclear medicine standards offerings and continued improvement in the startup of its medical device segment.
The firm posted a net loss of $112,694, down 27% from a net loss of $154,051 in the same period last year. It also reported a 6% decrease in revenue in its theranostics products segment, at $1.8 million compared with $1.9 million for the same period in 2024, which it attributed to a "two-week raw material outage" in the first quarter of 2025.
